Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide for Respiratory Failure with Metabolic Alkalosis
NCT00222534Phase 4Completed
- Sponsor
- University of Oslo School of Pharmacy
- Start
- Jan 2002
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acetazolamide in respiratory failure, metabolic alkalosis, sponsored by University of Oslo School of Pharmacy. Started Jan 2002; status: completed.
02
Drugs
acetazolamide
03
Conditions
respiratory failuremetabolic alkalosis
Beyond the preview
Go deeper on NCT00222534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00222534.